Cutaneousand gastrointestinal mastocytosis associated with cerebral toxoplasmosis

British Journal of Dermatology

Volumn 139, Issue 5, 1998, Pages 881-884

  Koeppel, M C ^a   Abitan, R ^a   Angeli, C ^a   Lafon, J ^b   Pelletier, J ^c   Sayag, J ^d  

^a HÔPITAL NORD   (France)

^b HÔPITAL DU BOCAGE   (France)

^c TIMONE HOSPITAL   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; CROMOGLYCATE DISODIUM; KETOTIFEN; SULFADIAZINE;

ADULT; ARTICLE; CASE REPORT; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; HUMAN; LABORATORY TEST; MALE; MAST CELL; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; TOXOPLASMOSIS; TREATMENT OUTCOME; GASTROINTESTINAL DISEASE; MASTOCYTOSIS; PARASITOLOGY; PATHOLOGY; TELANGIECTASIA;

ADULT; GASTROINTESTINAL DISEASES; HUMANS; MALE; MASTOCYTOSIS; TELANGIECTASIS; TOXOPLASMOSIS, CEREBRAL;

EID: 0031593823     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02518.x     Document Type: Article

References (18)

1. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol 1995; 32: 545-61.
2. Tnavis WD, Li CY, Bergstrahl EJ et al. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1988; 67: 345-68.
3. Cherner JA, Jensen RT, Dubois A et al. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology 1988; 95: 657-67.
4. Lescop J, Brinquin L, Schill H et al. Encéphalite toxoplasmique diffuse chez un sujet non immunodéprimé. J Radiol 1995; 76: 21-4.
5. Longley BJ, Morganroth GS, Tyrrell L et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993; 328: 1302-7.
6. Hamann K, Haas N, Grabbe J, Czarnetzki BM. Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 1995; 133: 203-8.
7. Weiss RR, Whiteker-Menezes D, Longley J et al. Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 1995; 104: 101-6.
8. Nagata H, Worobec AS, Oh CK et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in the peripheral blood mononuclear cells of patients who have mastocytosis with associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560-4.
9. Longley BJ, Tyrrell L, Lu SZ et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature Genet 1996; 12: 312-14.
10. Chao CC, Gekker G, Hu S, Peterson PK. Human microglial cell defense against Toxoplasma gondii. The role of cytokines. J Immunol 1994; 152: 1246-52.
11. Frei K, Bodmer S, Schwerdel C, Fontana A. Astrocytes of the brain synthesize interleukin-3 like factors. J Immunol 1985; 135: 4044-7.
12. Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996; 26: 13-19.
13. Mecheri S. Interactions mastocytes-cellules T: rôle du mastocyte dans la présentation de l'antigène aux cellules T. Rev Fr Allergol 1995; 35: 129-34.
14. Roberts CW, Ferguson DPJ, Jebbari HG et al. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immunity 1996; 64: 897-904.
15. Hunter CA. Remington JS. Immunopathogenesis of toxoplasmic encephalitis. J Infect Dis 1994; 170: 1057-67.
16. Tsuji K, Nakahata T, Takagi M et al. Effects of interleukin-5 and interleukin-4 on the development of 'connective tissue-type' mast cells: interleukin-5 supports their survival and interleukin-4 triggers and supports their proliferation synergistically with interleukin-3. Blood 1990; 75: 421-7.
17. Renoux M. Le mastocyte, cible et source de cytokines. Rev Fr Allergol 1995; 35: 120-4.
18. Voltz JM, Humbert P, Aubin F et al. Mastocyte et toxocarose: une association privilégiée. A propos de quatre observations, Nouv Dermatol 1995; (Suppl. REMI 14): 14.